These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 32383190

  • 1. Coumarin derivatives with anticancer activities: An update.
    Song XF, Fan J, Liu L, Liu XF, Gao F.
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
    [Abstract] [Full Text] [Related]

  • 2. Anti-breast Cancer Potential of Natural and Synthetic Coumarin Derivatives.
    Song F, Huo X, Guo Z.
    Curr Top Med Chem; 2021 Aug; 21(18):1692-1709. PubMed ID: 33655862
    [Abstract] [Full Text] [Related]

  • 3. Coumarin-containing hybrids and their anticancer activities.
    Zhang L, Xu Z.
    Eur J Med Chem; 2019 Nov 01; 181():111587. PubMed ID: 31404864
    [Abstract] [Full Text] [Related]

  • 4. Coumarins as Potential Anti-drug Resistant Cancer Agents: A Mini Review.
    Wang G, Sun S, Wu B, Liu J.
    Curr Top Med Chem; 2021 Nov 01; 21(19):1725-1736. PubMed ID: 33185162
    [Abstract] [Full Text] [Related]

  • 5. Current developments of coumarin-based anti-cancer agents in medicinal chemistry.
    Emami S, Dadashpour S.
    Eur J Med Chem; 2015 Sep 18; 102():611-30. PubMed ID: 26318068
    [Abstract] [Full Text] [Related]

  • 6. Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies.
    Thakur A, Singla R, Jaitak V.
    Eur J Med Chem; 2015 Aug 28; 101():476-95. PubMed ID: 26188907
    [Abstract] [Full Text] [Related]

  • 7. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
    Elshemy HAH, Zaki MA.
    Bioorg Med Chem; 2017 Feb 01; 25(3):1066-1075. PubMed ID: 28038941
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents.
    Yu H, Hou Z, Tian Y, Mou Y, Guo C.
    Eur J Med Chem; 2018 May 10; 151():434-449. PubMed ID: 29649740
    [Abstract] [Full Text] [Related]

  • 9. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
    Ma CC, Liu ZP.
    Anticancer Agents Med Chem; 2017 May 10; 17(3):395-403. PubMed ID: 26902599
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies.
    Menteşe E, Güner A, Polatlı E, Emirik M, Bektaş H, Kahveci B.
    Arch Pharm (Weinheim); 2021 Mar 10; 354(3):e2000284. PubMed ID: 33146895
    [Abstract] [Full Text] [Related]

  • 11. Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents.
    Yan G, Luo J, Han X, Zhang W, Pu C, Zhou M, Zhong X, Hou X, Hou MZ, Li R.
    Anticancer Agents Med Chem; 2021 Mar 10; 21(17):2351-2367. PubMed ID: 33511941
    [Abstract] [Full Text] [Related]

  • 12. Application of a Validated QSTR Model for Repurposing COX-2 Inhibitor Coumarin Derivatives as Potential Antitumor Agents.
    Tugcu G, Sipahi H, Aydin A.
    Curr Top Med Chem; 2019 Mar 10; 19(13):1121-1128. PubMed ID: 31210111
    [Abstract] [Full Text] [Related]

  • 13. Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents.
    Lv N, Sun M, Liu C, Li J.
    Bioorg Med Chem Lett; 2017 Oct 01; 27(19):4578-4581. PubMed ID: 28888820
    [Abstract] [Full Text] [Related]

  • 14. Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
    An R, Hou Z, Li JT, Yu HN, Mou YH, Guo C.
    Molecules; 2018 Sep 06; 23(9):. PubMed ID: 30200625
    [Abstract] [Full Text] [Related]

  • 15. Mito-methyl coumarin, a novel mitochondria-targeted drug with great antitumor potential was synthesized.
    Wang H, Xu W.
    Biochem Biophys Res Commun; 2017 Jul 15; 489(1):1-7. PubMed ID: 28546001
    [Abstract] [Full Text] [Related]

  • 16. Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
    Dandriyal J, Singla R, Kumar M, Jaitak V.
    Eur J Med Chem; 2016 Aug 25; 119():141-68. PubMed ID: 27155469
    [Abstract] [Full Text] [Related]

  • 17. Novel inhibitors of human histone deacetylases: design, synthesis and bioactivity of 3-alkenoylcoumarines.
    Seidel C, Schnekenburger M, Zwergel C, Gaascht F, Mai A, Dicato M, Kirsch G, Valente S, Diederich M.
    Bioorg Med Chem Lett; 2014 Aug 15; 24(16):3797-801. PubMed ID: 25042254
    [Abstract] [Full Text] [Related]

  • 18. Design, Synthesis, and In Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents.
    Wang Y, Liu H, Lu P, Mao R, Xue X, Fan C, She J.
    Chem Biol Drug Des; 2015 Oct 15; 86(4):637-47. PubMed ID: 25626768
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, antiproliferative activities, and DNA binding of coumarin-3-formamido derivatives.
    Shi J, Lu W, Chen J, Sun L, Yang S, Zhou M, Xu L, Ma Y, Yu L.
    Arch Pharm (Weinheim); 2021 Feb 15; 354(2):e2000236. PubMed ID: 33079446
    [Abstract] [Full Text] [Related]

  • 20. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
    Paul K, Bindal S, Luxami V.
    Bioorg Med Chem Lett; 2013 Jun 15; 23(12):3667-72. PubMed ID: 23642480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.